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These crazy days of the COVID-19 pandemic expose us to new lifestyles, new emotional experiences, and obviously, new challenges to our immune systems. It is almost surprising how fast organisms adapt to changes in their environment. In part, this remarkable capacity can be attributed to the plasticity of the primary systems that mediate our interactions with the external world: the nervous and the immune systems. The maturation of these systems is sculpted by experience and thus unique to each individual. As these systems also interact with each other, the adaptation of one system is expected to affect the other. This is especially relevant in the context of the stress response, a central process of communication between the brain and the periphery known to affect immune activity ([@bib11]).

To maintain homeostasis, the stress response must be tightly regulated. While a balanced and timely stress response prepares the body to deal with challenges and is vital for health, overwhelming and chronic stress is associated with the emergence of disease ranging from cardiovascular pathologies ([@bib8]) to cancer ([@bib1]). As organisms vary in their experiences, their stress mechanisms have to be adapted individually. Many of these adaptation processes take place during development. Indeed, early-life stress, which potentially predicts adverse life conditions, alters the activity of the neuroendocrine stress pathway, the hypothalamic-pituitary-adrenal (HPA) axis ([@bib10]). Stress-regulating pathways, and specifically the products of the HPA axis, glucocorticoids (GCs), are known to affect immune activity ([@bib11]). Thus, it is expected that early-life stress, via HPA axis activation, will also have major implications on the adult immune system. Surprisingly, in spite of extensive epidemiological data indicating that stress in early life is associated with increased risk of disease, especially cancer, at adulthood, underlying mechanisms are relatively poorly understood ([@bib7]). In their paper in *Cell*, [@bib6] provide molecular, cellular, and functional evidence for changes in the activity of adult CD8^+^ T cells in mice that experienced early-life stress ([Figure 1](#fig1){ref-type="fig"} ). The study offers a rare integrated perspective regarding the stress-induced changes in the HPA axis and their implications to the immune system's capacity to cope with bacteria and cancer at adulthood.Figure 1Perinatal Stress Reprograms the HPA Axis and Attenuates Anti-bacterial and Anti-tumor CD8 T Cell ActivityPerinatal glucocorticoids (GCs) exposure results in long-term reprogramming of the hypothalamic-pituitary-adrenal (HPA) axis. This is manifested by an increased mineralocorticoid receptor (MR) expression in the hippocampus of the adult offspring, thereby lowering the threshold for HPA negative feedback. The new set point of the HPA axis results in diminished levels of basal and stress induce GCs. Reduction in GCs signaling leads to attenuated CD8^+^ T cell function and activation, partially due to alterations in the transcription factor T-bet. Functionally, the reduction in CD8^+^ T cell activation results in impaired anti-tumor and anti-bacterial responses. Thus, early-life stress modifies adult immunity through reprogramming of the HPA axis.

To induce perinatal stress, the authors used dexamethasone (DEX), a synthetic analog of cortisol, in the drinking water of pregnant dams and tested long-term effects of this perinatal exposure to GCs. They found that perinatal DEX exposure reprogrammed the HPA axis manifested in the adult hippocampus by increased expression levels of one of the corticosterone (CORT) receptors, the mineralocorticoid receptor (MR). This adaptation enhanced the negative feedback of the HPA axis and decreased CORT levels under both basal and stressful conditions in adult mice. The authors then analyzed the effects of this attenuation in CORT levels on the immune system. They found that perinatal DEX exposure and the subsequent reduction in CORT levels specifically attenuated CD8^+^ T cell activation and proliferation in adulthood. Using a GCs receptor (GR) antagonist (RU486), a drug that blocks CORT synthesis (metyrapone), a mouse model in which GR signaling was eliminated specifically in T cells, and adrenalectomy, they demonstrated the involvement of CORT in mediating these effects on CD8^+^ T cells. They show that the diminished CD8^+^ T cell activity attenuated anti-tumor and anti-bacterial responses. To demonstrate the anti-bacterial effects, they used listeria monocytogenes expressing defined ovalbumin (OVA) antigen (LM-OVA). Hong et al. found that the antigen-specific CD8^+^ T cell response was significantly reduced in mice with perinatal DEX exposure. Antigen-loaded cells were killed less efficiently in perinatally DEX-exposed mice, and they had higher listeria burden. When OVA-specific CD8^+^ T cells (OT-I) from perinatally DEX-exposed mice were adoptively transferred, these cells showed diminished interferon γ (IFN-γ) and granzyme B expression in the recipient mice and lower OT-I T cell numbers. Suppression of CD8^+^ T cells was also evident in the context of the anti-tumor immune response. In the immunogenic B16-F10 mouse melanoma model, mice with perinatal DEX treatment showed accelerated tumor growth. CD45^+^ cells and the CD8^+^ T cell population were significantly reduced inside the tumors as well as in tumor-draining lymph nodes in perinatal DEX-treated mice. Even at the early stage of tumor development, their CD8^+^ T cells showed reduced interleukin 2 (IL-2) and granzyme B expression. To directly test the role of CD8^+^ T cells in anti-tumor responses, they utilized OT-I mice and the E.G7-OVA lymphoma, which expresses OVA antigen, and adoptively transferred OT-I CD8^+^ T cells from mice with or without perinatal DEX exposure. Mice that received OT-I cells from control animals effectively suppressed E.G7-OVA tumor growth, while mice that received OT-I cells from perinatally DEX-exposed mice failed to control tumor growth. Such attenuated suppression of the anti-tumor and anti-bacterial immune response is consistent with the evolving understanding that prolonged exposure to GCs enhances immune activation, although GCs are classically known for their anti-inflammatory effects ([@bib11]). These findings are also consistent with epidemiological data indicating that exposure to stressful events in early life increases the risk of cancer ([@bib7]). Furthermore, studies show that maternal exposure to a stressful life event during pregnancy increases the offspring's risk of infectious disease in childhood ([@bib5]). Now, the findings by Hong et al. suggest that this increased risk persists to adulthood.

The authors found that perinatal stress results in long-term epigenetic changes in naive CD8^+^ T cells. ATAC sequencing (ATAC-seq) analysis revealed that naive CD8^+^ T cells have reduced chromatin accessibility to the *Tbx21* locus, which encodes T-bet, a transcription factor that regulates naive T lymphocyte development. Interestingly, they also identified consensus GR binding sites in the affected sites of *Tbx21* locus. Given that the epigenetic effects of stress were shown to be passed across multiple generations ([@bib2]), these findings suggest that their immune outcomes may stretch beyond the lifetime of the individual.

The changes induced by perinatal GCs exposure affected the site at which immune cells develop: the bone marrow. The authors show that the effect is evident both in immune cells and within the bone marrow niche. By using bone marrow transplantation, Hong et al. demonstrate that alterations to the non-hematopoietic compartment of the bone marrow induced by perinatal stress contribute to the decreased activation of CD8^+^ T cells. This is in line with other studies indicating that the bone marrow is a niche sensitive to stress, although these studies mainly focused on the effects of another stress-regulating pathway, the sympathetic nervous system and its secretion of noradrenaline ([@bib4]).

The effects of early-life stress on the adult's immune system and capacity to cope with diseases is supported by extensive epidemiological data. However, stress is a very complex phenomenon. As the authors indicate, early-life stress models have been reported to result in hyperactive or hypoactive HPA axis, accompanied by increased or decreased GCs levels ([@bib10]). These discrepancies depend on the properties of the stressful stimulus, such as the duration of the stimulus and developmental time window ([@bib10]). Hong et al. identified a critical time point after birth at which a single GCs application was sufficient to reduce GCs levels in adulthood. They also show that different stress models have distinct effects on the long-term activity of the HPA axis, and thus, their implications to the immune system vary. Moreover, even stress at adulthood appears to have inconsistent effects on the immune system. Some suggest that stress suppresses immunity, while others provide evidence that stress can induce inflammation and autoimmune conditions ([@bib12]). The current study characterized the cellular and functional effects of stress on a specific immune subset. However, not only is stress a complex system with numerous pathways and outcomes, it also affects most systems of the organism, including metabolism and blood pressure, each of which can themselves affect immunity; such interactions highlight the need to examine the effects of stress at the level of the physiology of the entire organism. The current study takes an important step toward the fulfillment of the emerging need for a systematic yet detailed characterization of the stress response, and its implications on immunity and physiology in general. Stress is evident in our daily lives, especially as the world is facing the COVID-19 pandemic. Given the prominent effects of stress on immunity, it is essential that we understand the underlying mechanisms of this interaction, as such an understanding can be crucial for the capacity to maintain our health during these trying times.
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